SURVYR

NHC

National HealthCare Corporation
$211.81
−$11.89 (5.32%)Oct 27 close
Health CareS&P 600 CompareTechnicals
-7%+22%+51%+80%+109%Oct 2025Oct 2026Apr 202652w high $248.2052w low $118.14
NHCSPY
Wall St. Highest PT $314.59 (+48.5%) Wall St. Avg PT $257.86 (+21.7%)
$118$169$221$272$324POC $225Hi $315Avg $258
Underwater Drawdown %Max DD -14.6%Current -14.6%
0.0%-14.6%
Relative Strength vs SPY+65.0% vs SPYOutperforming
+110%0%-110%
1W
−$36.13 (14.57%)
1M
−$14.87 (6.56%)
3M
−$18.50 (8.03%)
6M
+$38.26 (22.04%)
YTD
+$76.11 (56.09%)
1Y
+$93.20 (78.58%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for NHC
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$3.3B
P/E (last 12 months)23.8
P/E (next 12 months, estimated)492.6
52-week range$118.14 – $248.20
Revenue growth (latest quarter vs a year ago)+8.8%
Dividend yield1.20%

What they do

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
94th percentile in sector
A
12-1 return: +86.5%
Percentile within its GICS sector across the S&P 1500.
Growth
52nd percentile in sector
C+
Revenue growth (YoY): +8.8%
Percentile within its GICS sector across the S&P 1500.
Value
18th percentile in sector
D
Forward E/P: 0.2% · EBITDA/EV: 5.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
56th percentile in sector
B-
Profit margin: +9.0% · Return on equity: +13.3%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Held by 1 of 7 live models: Momentum Blend.

Momentum Blend
4.3% of the book · Core sleeve
Held
Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
New Highs Growth
Outside this model's universe or screens
SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
SURVYR. Long Book
Not in the current book
Why it's in the Momentum Blend

In the Core sleeve: one of the steadiest 12-month uptrends in its universe (the model's smooth-trend momentum score).

What would knock it out: Re-checked at each monthly rebalance (next Oct 30); leaves if it no longer makes the Core selection. The latest preview drops it.

Earnings & events

NHC earningsNext report in 9 days
Next report · quarter Sep 2026
Fri Nov 6, 2026Before the open
EPS consensus–
Revenue consensus$0
Last 4 quarters · EPS vs estimate
May 7, 2015$0.77est $0.90−14.6%Below estimates
Feb 20, 2015$0.88est $0.93−5.5%Below estimates
Nov 6, 2014$0.75est $0.85−11.3%Below estimates
Aug 6, 2014$0.72est $0.76−4.8%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-27 18:03:53 ET
13-0513-0813-1114-0514-0814-1115-0215-050.001.19
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$408.0M+8.8%
2026-03-31$381.8M–
2025-12-31$386.5M–
2025-09-30$382.7M–
2025-06-30$374.9M–

Recent dividends

2026-09-30: $0.670 · 2026-06-30: $0.670 · 2026-03-31: $0.640 · 2025-12-31: $0.640 · 2025-09-30: $0.640 · 2025-06-30: $0.640 · 2025-03-28: $0.610 · 2024-12-30: $0.610

News & catalysts

More news
National HealthCare (NHC) Stock Trades Below Fair Value On A 289% Run
Simply Wall St. · Oct 18
Raymond James Initiates Coverage on National Healthcare With Outperform Rating, $20 Price Target
MT Newswires · Oct 13
National Healthcare Insider Sold Shares Worth $1,087,650, According to a Recent SEC Filing
MT Newswires · Sep 24
NHC Debuts a New Model for Retail Wellness with Brentwood Flagship Store
Business Wire · Sep 17
National Healthcare Insider Sold Shares Worth $609,669, According to a Recent SEC Filing
MT Newswires · Sep 14
Insider trades
Dodson Vicki L
Sr.VP Patient Srvcs · 2026-09-22
Sell
$1.1M
Kidd Brian F
SVP, CFO · 2026-09-11
Sell
$1.5M
Mccreary Josh A
Senior VP & General Counsel · 2026-09-10
Sell
$15.3K
Mccreary Josh A
Senior VP & General Counsel · 2026-09-10
Sell
$290.6K
Mccreary Josh A
Senior VP & General Counsel · 2026-09-10
Sell
$176.6K
Mccreary Josh A
Senior VP & General Counsel · 2026-09-10
Sell
$127.2K
Flatt Ben Anderson Sr
Senior VP & CIO · 2026-08-28
Sell
$222.5K
Gifford David R.
Director · 2026-08-25
Sell
$401.0K
Flatt Ben Anderson Sr
Senior VP & CIO · 2026-08-25
Sell
$227.0K
Flatt Ben Anderson Sr
Senior VP & CIO · 2026-08-20
Sell
$237.0K
Flatt Stephen Fowler
Director, CEO · 2026-08-19
Sell
$355.6K
Flatt Ben Anderson Sr
Senior VP & CIO · 2026-08-19
Sell
$237.2K

Stats refreshed 2026-10-27 18:03:53 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026